{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:58Z","timestamp":1792686478027,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["PKU2021LCXQ008"],"award-info":[{"award-number":["PKU2021LCXQ008"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3602000"],"award-info":[{"award-number":["2022YFC3602000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871281"],"award-info":[{"award-number":["81871281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801618"],"award-info":[{"award-number":["81801618"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cyto.2025.156953","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T02:44:42Z","timestamp":1747881882000},"page":"156953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The clinical characteristics and significance of novel inflammatory biomarkers in patients with polymyalgia rheumatica: A single-center study from China"],"prefix":"10.1016","volume":"192","author":[{"given":"Ruohan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cyto.2025.156953_bb0005","first-page":"351","article-title":"High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community","volume":"9","author":"Noltorp","year":"1991","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.cyto.2025.156953_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/rheumatology\/34.3.261","article-title":"Epidemiology and mortality in 220 patients with polymyalgia rheumatica","volume":"34","author":"Schaufelberger","year":"1995","journal-title":"Br. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.cyto.2025.156953_bb0015","first-page":"1739","article-title":"The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, South Norway: a prospective study 1987-94","volume":"24","author":"Gran","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2025.156953_bb0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4078\/jrd.2014.21.6.297","article-title":"Epidemiology of Polymyalgia Rheumatica in Korea","volume":"21","author":"Kim","year":"2014","journal-title":"J. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2025.156953_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102995","article-title":"Immune system activation in polymyalgia rheumatica: which balance between autoinflammation and autoimmunity? A systematic review","volume":"21","author":"Hysa","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2025.156953_bb0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/ard.2008.103663","article-title":"Circulating cytokines in active polymyalgia rheumatica","volume":"69","author":"Alvarez-Rodriguez","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.cyto.2025.156953_bb0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13075-016-1072-4","article-title":"Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study","volume":"18","author":"Galbo","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.cyto.2025.156953_bb0040","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/rheumatology\/keu526","article-title":"Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica","volume":"54","author":"van der Geest","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.cyto.2025.156953_bb0045","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/37.7.766","article-title":"Cytokines and adhesion molecules in patients with polymyalgia rheumatica","volume":"37","author":"Uddhammar","year":"1998","journal-title":"Br. J. Rheumatol."},{"issue":"11","key":"10.1016\/j.cyto.2025.156953_bb0050","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2006.051979","article-title":"Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis","volume":"65","author":"Cutolo","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.cyto.2025.156953_bb0055","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/rheumatology\/39.6.624","article-title":"The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica","volume":"39","author":"Straub","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.cyto.2025.156953_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105342","article-title":"Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio reflect disease activity and flares in patients with systemic lupus erythematosus - a prospective study","volume":"89","author":"Cho","year":"2022","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.cyto.2025.156953_bb0065","first-page":"11","article-title":"Study neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patient with rheumatoid arthritis","volume":"70","author":"Khan","year":"2022","journal-title":"J. Assoc. Physicians India"},{"issue":"9","key":"10.1016\/j.cyto.2025.156953_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23000","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica","volume":"33","author":"Jung","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"issue":"29","key":"10.1016\/j.cyto.2025.156953_bb0075","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007546","article-title":"The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset still\u2019s disease: a STROBE-compliant retrospective observational analysis","volume":"96","author":"Seo","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.cyto.2025.156953_bb0080","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.cyto.2025.156953_bb0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","article-title":"2012 provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism\/American College of Rheumatology collaborative initiative","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.cyto.2025.156953_bb0090","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum."},{"issue":"7647","key":"10.1016\/j.cyto.2025.156953_bb0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.39514.653588.80","article-title":"Polymyalgia rheumatica","volume":"336","author":"Michet","year":"2008","journal-title":"BMJ"},{"issue":"9634","key":"10.1016\/j.cyto.2025.156953_bb0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cyto.2025.156953_bb0105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.cyto.2025.156953_bb0110","first-page":"1750","article-title":"Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica","volume":"25","author":"Gonzalez-Gay","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2025.156953_bb0115","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221149963","article-title":"Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica - a prospective cohort study","volume":"15","author":"Burg","year":"2023","journal-title":"Ther. Adv. Musculoskelet Dis."},{"issue":"1","key":"10.1016\/j.cyto.2025.156953_bb0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/kead189","article-title":"Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica","volume":"63","author":"De Miguel","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.cyto.2025.156953_bb0125","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.semarthrit.2018.05.007","article-title":"Predictors of positive (18)F-FDG PET\/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica","volume":"48","author":"Prieto-Pena","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cyto.2025.156953_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.55563\/clinexprheumatol\/6z2rdg","article-title":"Clinical implications of fever at diagnosis in polymyalgia rheumatica: an age- and sex-matched case control study of 120 patients","volume":"40","author":"Betrains","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2025.156953_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.20901","article-title":"Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective followup study","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.cyto.2025.156953_bb0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.semarthrit.2019.12.005","article-title":"Tocilizumab in isolated polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Akiyama","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cyto.2025.156953_bb0145","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/annrheumdis-2021-221126","article-title":"Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2\/3 randomised controlled trial","volume":"81","author":"Bonelli","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.cyto.2025.156953_bb0150","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jama.2022.15459","article-title":"Effect of tocilizumab on disease activity in patients with active polymyalgia Rheumatica receiving glucocorticoid therapy: a randomized clinical trial","volume":"328","author":"Devauchelle-Pensec","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cyto.2025.156953_bb0155","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/rheumatology\/key431","article-title":"Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis","volume":"58","author":"Manzo","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"39","key":"10.1016\/j.cyto.2025.156953_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035385","article-title":"Diagnostic difficulties in polymyalgia rheumatica cases with normal erythrocyte sedimentation rate and C-reactive protein values","volume":"102","author":"Kara","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.cyto.2025.156953_bb0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/ijmr.IJMR_1676_18","article-title":"Potential of neutrophil to lymphocyte ratio in predicting sustained remission in rheumatoid arthritis compared to other immune activation markers","volume":"152","author":"Chandrashekara","year":"2020","journal-title":"Indian J. Med. Res."},{"issue":"5","key":"10.1016\/j.cyto.2025.156953_bb0170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/jcla.21908","article-title":"The association between neutrophil\/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis","volume":"30","author":"Mercan","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.cyto.2025.156953_bb0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/1756-185X.14000","article-title":"Neutrophil to lymphocyte ratio predicts glucocorticoid resistance in polymyalgia rheumatica","volume":"24","author":"Owen","year":"2021","journal-title":"Int. J. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2025.156953_bb0180","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/ced.14432","article-title":"A cutoff value for the systemic immune-inflammation index in determining activity of Behcet disease","volume":"46","author":"Tanacan","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"issue":"9","key":"10.1016\/j.cyto.2025.156953_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23964","article-title":"Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis","volume":"35","author":"Wu","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"7","key":"10.1016\/j.cyto.2025.156953_bb0190","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/nep.13491","article-title":"Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naive patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"24","author":"Kim","year":"2019","journal-title":"Nephrology (Carlton)"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466625001000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T15:15:29Z","timestamp":1749568529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466625001000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":38,"alternative-id":["S1043466625001000"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156953","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical characteristics and significance of novel inflammatory biomarkers in patients with polymyalgia rheumatica: A single-center study from China","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2025.156953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156953"}}